BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma using Functional Respiratory Imaging

Trial Identifier: D3250R00107
Sponsor: AstraZeneca
Start Date: October 2022
Primary Completion Date: July 2024
Study Completion Date: July 2024
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation
English Translation
English Translation
Spanish Translation
Spanish Translation
French Translation
French Translation
Dutch Translation
Portuguese Translation

Trial Locations

Country Location
AU Clayton, AU, 3168
AU Toorak Gardens, AU, 5065
BE Liege, BE, 4000
BE Namur, BE, 5101
ES Barcelona, ES, 8003
ES Barcelona, ES, 08006
ES Barcelona, ES, 08017
ES Madrid, ES, 28007
ES Santander, ES, 39008
ES Villarreal (Castellón), ES, 12540
FR Montpellier Cedex 5, FR, 34295
GB Bradford, GB, BND9 6RJ
GB Nottingham, GB, NG5 1PB
PT Lisboa, PT, 1649-035
PT Porto, PT, 4100-180
US, CA Walnut Creek, CA, US, 94598
US, FL Loxahatchee, FL, US, 33470
US, FL Plantation, FL, US, 33324
US, IN Greenwood, IN, US, 46143
US, KY Lexington, KY, US, 40536
US, MO Saint Louis, MO, US, 63110
US, PA Du Bois, PA, US, 15801
US, TX Tyler, TX, US, 75708
US, TX Webster, TX, US, 77598
US, VA Charlottesville, VA, US, 22908